A 16-year-old female high school junior with a history of recurrent patellar instability presented with left knee pain following a patellar dislocation event.
Two weeks earlier, she stepped onto a slippery deck, causing her left knee to twist internally and her patella to dislocate laterally. After the incident, she reported that her patella spontaneously reduced, but she had been unable to ambulate afterward due to pain, swelling and a sensation of patellar instability. Prior treatments for her patellar instability included anti-inflammatory medications, crutches, bracing, rest, activity

Editor’s note: This is a developing news story. Please check back soon for updates.
At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients with open-angle glaucoma or ocular hypertension with concomitant cataract.
According to a press release from SpyGlass Pharma, 104 patients were randomly assigned 2:1:1 to receive 78 µg Bimatoprost Drug Pad-IOL System (BIM-IOL System) (51 patients) with daily administration of artificial tear drops, 39 µg BIM-IOL System (23 patients) with daily administration of artificial tear drops, or

The FDA approved secukimumab for children aged 12 years and older with moderate to severe hidradenitis suppurativa, Novartis announced in a press release.
The approval makes secukinumab (Cosentyx) the first IL-17A inhibitor approved for a pediatric population.
“Hidradenitis suppurativa often begins in adolescence and can cause irreversible scarring and disabilities,” Alexa B. Kimball, MD, MPH, lead investigator of the SUNSHINE and SUNRISE clinical trials in adult HS patients, president and CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center and

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD.
In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety Cholesterol guideline, there have been major advances in tests, tools and treatments to target dyslipidemia for improvement in CV health.
The newly released 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia incorporates these updates and the latest evidence into a comprehensive document featuring 18 easy-to-follow figures and 27 tables across more than 90 pages of evidence-based

An updated guideline for the management of dyslipidemia emphasized enhancing health-related behaviors and consideration of early initiation of lipid-lowering therapy, even in adults as young as 30 years.
The American Heart Association and American College of Cardiology issued an updated guideline for the treatment of dyslipidemia and prevention of atherosclerotic CVD, with new considerations for LDL targets, coronary artery calcium scoring and measuring lipoprotein(a).
The updated guideline was developed in collaboration with and endorsed by the American Association of Cardiovascular and

Last month, Minnesota reported what it said is the country’s “largest known outbreak” of Trichophyton mentagrophytes genotype VII, a sexually transmitted fungus that can cause severe ringworm.
Also known as TMVII, the infection appears as “round, coin-like rashes that are red and irritated, sometimes with bumps and pimples on top,” the Minnesota Department of Health noted.
The rash can be found on the face, buttocks, genitals, arms, legs and abdomen and can lead to scarring and secondary infections, but is treatable with oral antifungals. It can be confused with other, more common infections,

ORLANDO — Some chronic diseases disproportionately affect Hispanic, Latino and African American people, and optometrists can better manage them by displaying empathy and establishing trust, according to a panel discussion at Vision Expo.
The first step to reducing fear surrounding the discussion of disease management should be to acknowledge it, according to panelist Glenda Aleman-Moheeputh, OD, a board member of Latinos en Optometry, one of the sponsors of the event.
“Let the patient know you understand that when they’re coming to you, they’re fearful,” she said.

After a record-setting year for measles in 2025, transmission of the virus has not slowed.
Just 2 1/2 months into 2026, there have been 1,362 confirmed measles cases in 31 states — more than half of the total for all of 2025, when the U.S. set a 33-year high with 2,284 cases.
The largest outbreaks can be traced to 2025 and are occurring in Arizona (56 in 2026; 276 total), Utah (209; 405) and South Carolina (664; 993). According to the CDC, 12 new outbreaks have started in 2026. States with rapidly growing case counts include Florida (132), Texas (93), Washington (26) and California (29).
More

A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and improve health outcomes for their Black patients, an expert said.
BlackDoctor is a “leading health and wellness destination for Black people” that works to “leverage culture, content and technology to transform people’s lives for the better,” according to its website. But now, it is expanding beyond a consumer health platform to become a dual-platform clinical delivery model, according to a press release.
There are some key aspects to the expansion rollout: BlackDoctor

There was a decrease in early prenatal care across the United States in the last few years, nearly reversing years of prior growth, according to recently published CDC data.
The results show “that delayed or absent prenatal care is becoming increasingly common, driven by a combination of access barriers and ongoing system strain,” Kim Bruno, DC, CCN, associate director medical science liaison at Sera Prognostics, the developer of the PreTRM test, told Healio.
In the analysis, Michelle J.K. Osterman, MHS, a nurse consultant at the Health Resources and Services Administration, and